InsiderFlow

MNPR

Monopar Therapeutics Inc.$103.93-4.39 (-4.05%)
Prev Close$108.32·MCap$736.6M·P/E·Vol63.9K·Yield

Buys (12M)

1

$104.9K

Sells (12M)

8

$1.81M

Net Activity

Net Seller

$1.71M

Active Insiders

7

last 12 mo

Over the past 12 months, insider activity at Monopar Therapeutics Inc. (MNPR) has been dominated by selling, with 1 insider purchase totaling $104.9K and 8 insider sales totaling $1.81M. The most recent insider transaction was by Anderson Raymond (director), who sold $351.2K worth of shares on Aug 27, 2026. Monopar Therapeutics Inc. operates in the Healthcare sector, within the Biotechnology industry, with a market cap of $736.6M.

MNPR Insider Trading Activity

DateInsiderTypeValue
Aug 27, 2026 Anderson RaymondSell$351.2K
Aug 27, 2026 Tsuchimoto Kim RSell$455.6K
Aug 27, 2026 RIOUX PATRICESell$111.26
Dec 31, 2025 Cittadine AndrewSell$123.4K
Dec 31, 2025 Robinson ChandlerSell$167.0K
Dec 26, 2025 Vu Quan AnhBuy$104.9K
Dec 18, 2025 KLAUSNER ARTHUR JSell$343.9K
Sep 30, 2025 Cittadine AndrewSell$154.8K
Sep 30, 2025 Robinson ChandlerSell$216.1K
Jul 14, 2025 STARR CHRISTOPHER MSell$672.1K0.5% OS
Jul 14, 2025 Tsuchimoto Kim RSell$356.2K
Jun 30, 2025 Cittadine AndrewSell$107.0K
Jun 30, 2025 Robinson ChandlerSell$209.8K
Mar 31, 2025 Cittadine AndrewSell$27.1K
Mar 31, 2025 Robinson ChandlerSell$43.8K
Mar 4, 2025 Robinson ChandlerSell$55.8K
Oct 30, 2024 Radhakrishnan KarthikBuy$25.2K
Jun 21, 2024 Cittadine AndrewBuy$25.6K
Jun 17, 2024 Cittadine AndrewBuy$32.9K0.5% OS
Jun 5, 2024 Cittadine AndrewBuy$18.5K
May 31, 2024 Cittadine AndrewBuy$23.1K0.5% OS
Nov 16, 2022 Cittadine AndrewBuy$49.7K

MNPR Insider Buying Activity

The following table shows recent insider purchases of Monopar Therapeutics Inc. (MNPR) stock reported via SEC Form 4 filings.

DateInsiderTypeValue
Dec 26, 2025 Vu Quan AnhBuy$104.9K
Oct 30, 2024 Radhakrishnan KarthikBuy$25.2K
Jun 21, 2024 Cittadine AndrewBuy$25.6K
Jun 17, 2024 Cittadine AndrewBuy$32.9K0.5% OS
Jun 5, 2024 Cittadine AndrewBuy$18.5K
May 31, 2024 Cittadine AndrewBuy$23.1K0.5% OS
Nov 16, 2022 Cittadine AndrewBuy$49.7K

MNPR Insider Selling Activity

The following table shows recent insider sales of Monopar Therapeutics Inc. (MNPR) stock reported via SEC Form 4 filings.

DateInsiderTypeValue
Aug 27, 2026 Anderson RaymondSell$351.2K
Aug 27, 2026 Tsuchimoto Kim RSell$455.6K
Aug 27, 2026 RIOUX PATRICESell$111.26
Dec 31, 2025 Cittadine AndrewSell$123.4K
Dec 31, 2025 Robinson ChandlerSell$167.0K
Dec 18, 2025 KLAUSNER ARTHUR JSell$343.9K
Sep 30, 2025 Cittadine AndrewSell$154.8K
Sep 30, 2025 Robinson ChandlerSell$216.1K
Jul 14, 2025 STARR CHRISTOPHER MSell$672.1K0.5% OS
Jul 14, 2025 Tsuchimoto Kim RSell$356.2K
Jun 30, 2025 Cittadine AndrewSell$107.0K
Jun 30, 2025 Robinson ChandlerSell$209.8K
Mar 31, 2025 Cittadine AndrewSell$27.1K
Mar 31, 2025 Robinson ChandlerSell$43.8K
Mar 4, 2025 Robinson ChandlerSell$55.8K

MNPR Insiders

RIOUX PATRICE

other: Acting Chief Medical Officer

Sold $111.26
1 tradesLast: Aug 27, 2026
Tsuchimoto Kim R

Director

Sold $811.8K
2 tradesLast: Aug 27, 2026
Anderson Raymond

director

Sold $351.2K
1 tradesLast: Aug 27, 2026
Cittadine Andrew

Chief Operating Officer

Bought $149.7KSold $412.3K
9 tradesLast: Dec 31, 2025
Robinson Chandler

Chief Executive Officer

Sold $692.6K
5 tradesLast: Dec 31, 2025
Vu Quan Anh

Chief Financial Officer

Bought $104.9K
1 tradesLast: Dec 26, 2025
KLAUSNER ARTHUR J

Director

Sold $343.9K
1 tradesLast: Dec 18, 2025
STARR CHRISTOPHER M

Director

Sold $672.1K
1 tradesLast: Jul 14, 2025
Radhakrishnan Karthik

Chief Financial Officer

Bought $25.2K
1 tradesLast: Oct 30, 2024